000 | 01255 a2200313 4500 | ||
---|---|---|---|
005 | 20250518063147.0 | ||
264 | 0 | _c20191209 | |
008 | 201912s 0 0 eng d | ||
022 | _a1878-3511 | ||
024 | 7 |
_a10.1016/j.ijid.2019.09.027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Oers, Jos A H | |
245 | 0 | 0 |
_aWhy would procalcitonin perform better in patients with a SOFA-score less than 8? _h[electronic resource] |
260 |
_bInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _c12 2019 |
||
300 |
_a185-186 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 | _aCritical Illness |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOrgan Dysfunction Scores |
650 | 0 | 4 | _aPatients |
650 | 0 | 4 | _aProcalcitonin |
700 | 1 | _aNijsten, Maarten W | |
700 | 1 | _ade Jong, Evelien | |
700 | 1 | _aBeishuizen, Albertus | |
700 | 1 | _ade Lange, Dylan W | |
773 | 0 |
_tInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _gvol. 89 _gp. 185-186 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijid.2019.09.027 _zAvailable from publisher's website |
999 |
_c30174904 _d30174904 |